Ascendis Pharma A-S
Price & Volume
Stats
See more52W Range | $160.86-$271.89 |
Market Cap | $17.5B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $865.7M |
Revenue Growth (YoY) | 144.3% |
Gross Profit (12 Mos) | $770.8M |
Diluted EPS | $8.63 |
News
See moreYahoo Finance • yesterday
Ascendis Pharma added to Russell 3000, Russell 1000 and other U.S. indexes
Yahoo Finance • yesterday
Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®
Yahoo Finance • 14 days ago
Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism
Yahoo Finance • 15 days ago
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week
About
CEO | Mr. Jan Moller Mikkelsen |
CFO | Mr. Scott T. Smith |
Address | Tuborg Boulevard 12, Hellerup, Denmark, 2900 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,189 |